For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Dermatology Diagnostic Devices are designed for evaluating skin lesions suspected of malignancy.
Scope of the Report:
Dermatology Diagnostics Devices is mainly used in Skin Cancer, Psoriasis, Acne and Others, and in the next five years, the global consumption of Dermatology Diagnostics Devices will maintain more than 6% annual growth rate.
Dermatology Diagnostics Devices include Imaging Equipment, Microscopes & Trichoscopes and Dermotoscopes. And in Imaging Equipment in the largest product in 2016 the market share in over 70%.
North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 27% in 2016.
GE Healthcare, Philips Healthcare, Siemens Healthcare, Carl Zeiss, Leica Microsystems, Fotofinder Systems, Caliber I.D, Dermlite, Heine, Dino-Lite, Canfield, WelchAllyn, AMD Global, etc. are the leaders of the industry, with high-end customers.
With the development of medical technology level, more and more companies will participate in this industry. The use in hospital and clinic will be more and more.
The worldwide market for Dermatology Diagnostics Devices is expected to grow at a CAGR of roughly 7.0% over the next five years, will reach 1010 million US$ in 2024, from 670 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Dermatology Diagnostics Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- GE Healthcare
- Philips Healthcare
- Siemens Healthcare
- Carl Zeiss
- Leica Microsystems
- Nikon Corporation
- Fotofinder Systems
- Caliber I.D.
- Dermlite
- Heine Optotechnik
- Welch Allyn
- AMD Global Telemedicine
- Michelson Diagnostics
- Longport
- Verisante Technology
- Strate Skin Sciences
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Imaging Equipment
- Microscopes & Trichoscopes
- Dermotoscopes
Market Segment by Applications, can be divided into
- Skin Cancer
- Psoriasis
- Acne
- Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatology Diagnostics Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology Diagnostics Devices, with price, sales, revenue and global market share of Dermatology Diagnostics Devices in 2017 and 2018.
Chapter 3, the Dermatology Diagnostics Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology Diagnostics Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Dermatology Diagnostics Devices market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Dermatology Diagnostics Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.